Grant: Team Grant: HIV/AIDS Comorbidities Prevention and Healthy Living - LOI
University of Alberta
$25,000.00
Canadian NeuroAIDS Research Team (CNART): interactions with aging and co-infections
EF 2017-18
Résumé
Scientists have made extraordinary advances in understanding and treating HIV infection over the past 20 years. Still, the capacity for HIV-1 to infect and damage the nervous system continues to be a major problem for people who are living with HIV/AIDS, even with antiretroviral therapy. The chief consequences when HIV-1 infects the nervous system are difficulties in thinking processes and pain from damaged nerves. These problems are called NeuroAIDS. They reduce quality of life, impair sleep, diminish employability, affect mood and isolate people socially. Over the past 5 years, our Canadian NeuroAIDS Research Team (CNART) has defined how often these problems occur and their symptoms. We have discovered new disease processes and used those to develop and test new diagnostic techniques and therapies. For example, we uncovered new biomarkers for people with thinking problems and pain from NeuroAIDS, and found new therapies for both problems that we are now testing in clinical trials. We have also identified specific sex and gender factors that make some groups more vulnerable to problems with cognitive functions (e.g., women from sub-Saharan Africa) and pain from damaged nerves (e.g., gay and bisexual men with long-standing HIV infection).
New problems from NeuroAIDS are now emerging that require deeper analysis, particularly related to sex and gender diversity. These problems include the impact of aging and of having other infections at the same time as HIV/AIDS. CNART will broaden its work by adopting a crosscutting strategy to a spectrum of NeuroAIDS problems. We will map fundamental molecular pathways and use them to analyze clinical symptoms and risk factors for NeuroAIDS. This strategy will generate new options for diagnosis and therapies. It will also build a broader community appreciation and understanding of NeuroAIDS and its related problems.
Programme
Team Grant: HIV/AIDS Comorbidities Prevention and Healthy Living - LOI
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
367829
Name
Power Christopher
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
HIV/AIDS Comorbidities Prevention and Healthy Living
Projecttitle
Canadian NeuroAIDS Research Team (CNART): interactions with aging and co-infections
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$25,000
Cihrequipment2
$0
Programname2
Team Grant: HIV/AIDS Comorbidities Prevention and Healthy Living - LOI
Keyworddelim
Aging; Biomarker; Ethnic Diversity; Hepatitis C Virus; Hiv/Aids; Neuroaids; Neurocognitive Impairment; Neuropathic Pain; Sex And Gender Diversity; Syphillis
Abstract
Scientists have made extraordinary advances in understanding and treating HIV infection over the past 20 years. Still, the capacity for HIV-1 to infect and damage the nervous system continues to be a major problem for people who are living with HIV/AIDS, even with antiretroviral therapy. The chief consequences when HIV-1 infects the nervous system are difficulties in thinking processes and pain from damaged nerves. These problems are called NeuroAIDS. They reduce quality of life, impair sleep, diminish employability, affect mood and isolate people socially. Over the past 5 years, our Canadian NeuroAIDS Research Team (CNART) has defined how often these problems occur and their symptoms. We have discovered new disease processes and used those to develop and test new diagnostic techniques and therapies. For example, we uncovered new biomarkers for people with thinking problems and pain from NeuroAIDS, and found new therapies for both problems that we are now testing in clinical trials. We have also identified specific sex and gender factors that make some groups more vulnerable to problems with cognitive functions (e.g., women from sub-Saharan Africa) and pain from damaged nerves (e.g., gay and bisexual men with long-standing HIV infection).
New problems from NeuroAIDS are now emerging that require deeper analysis, particularly related to sex and gender diversity. These problems include the impact of aging and of having other infections at the same time as HIV/AIDS. CNART will broaden its work by adopting a crosscutting strategy to a spectrum of NeuroAIDS problems. We will map fundamental molecular pathways and use them to analyze clinical symptoms and risk factors for NeuroAIDS. This strategy will generate new options for diagnosis and therapies. It will also build a broader community appreciation and understanding of NeuroAIDS and its related problems.
Competitiondate
201706
Approvedterm2
0 yr 6 mths
Pinamesdelim
Power, Christopher; Fujiwara, Esther
Approvedterm
0 an 6 mois
Cihrcontribution2
~ $25,000~ $0~